ArticleHepatology forum2025

Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort.

Eda Kaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.